{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:52:47Z","timestamp":1777665167390,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Multiple system atrophy (MSA) is a rare degenerative neurological disorder in adults. It induces parkinsonian and\/or cerebellar syndrome associated with dysautonomia. Pharyngolaryngeal symptoms are common. Our aim is to describe the Pharyngolaryngeal semiology on one hand, and to ascertain whether the presence of these symptoms represents a prognostic factor for MSA on the other.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Thus, we carried out a retrospective, single-centre study, on a cohort receiving care at the centre of reference for MSA. The patients were referred for otorhinolaryngology assessment. The data was collected over the year 2020 with the help of computer software from the university hospital centre (UHC). Firstly, we described the Pharyngolaryngeal semiology specific to MSA by questioning patients, and by the results of nasofibroscopic examinations and swallowing tests. We then used multivariate analysis of variance to describe the prognostic factors of MSA progression (in UMSARS I and II points per month of progression) and survival (number of years between the first symptoms and death).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study included a hundred and one patients and made it possible to define a Pharyngolaryngeal semiology profile of MSA, which is: a reduction in laryngeal mobility (primarily vocal cord abduction defects), abnormal movements (particularly at rest or when initiating a movement) and a defect in the protection mechanisms of the upper airways. The swallowing difficulties are moderate and the main mechanisms are delayed pharyngeal swallow and\/or an oro-pharyngeal transport defect. In the multivariate analyses, the contributing factors are laryngeal anomalies, modification of solid food to fluid food and nutritional complication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>ENT specialists should pay close attention to problems in the Pharyngolaryngeal dynamic and then consider a neurological cause. They can also itemize the clinical factors that could have a negative effect on the prognosis of the patient with MSA. Indeed, early detection makes it possible to provide care for respiratory and nutritional complications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00405-022-07410-x","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T18:04:28Z","timestamp":1651773868000},"page":"4473-4483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharyngolaryngeal semiology and prognostic factors in multiple system atrophy"],"prefix":"10.1007","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9371-7013","authenticated-orcid":false,"given":"N.","family":"El Fassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Gallois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fichaux-Bourrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pavy le Traon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Woisard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"7410_CR1","unstructured":"Roberts M (2019) Etude polysomnographique des troubles respiratoires et de la dysautonomie au cours du sommeil dans l\u2019atrophie multisyst\u00e9matis\u00e9e. http:\/\/thesesante.ups-tlse.fr\/2891\/. (Published online October 1, 2019. Accessed Apr 6, 2021)"},{"issue":"3","key":"7410_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372(3):249\u2013263. https:\/\/doi.org\/10.1056\/NEJMra1311488","journal-title":"N Engl J Med"},{"issue":"7","key":"7410_CR3","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","volume":"14","author":"PA Low","year":"2015","unstructured":"Low PA, Reich SG, Jankovic J et al (2015) Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 14(7):710\u2013719. https:\/\/doi.org\/10.1016\/S1474-4422(15)00058-7","journal-title":"Lancet Neurol"},{"issue":"Pt 12","key":"7410_CR4","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1093\/brain\/awv274","volume":"138","author":"EA Coon","year":"2015","unstructured":"Coon EA, Sletten DM, Suarez MD et al (2015) Clinical features and autonomic testing predict survival in multiple system atrophy. Brain 138(Pt 12):3623\u20133631. https:\/\/doi.org\/10.1093\/brain\/awv274","journal-title":"Brain"},{"issue":"4","key":"7410_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000444325","volume":"46","author":"C Starhof","year":"2016","unstructured":"Starhof C, Korbo L, Lassen CF, Winge K, Friis S (2016) Clinical features in a Danish population-based cohort of probable multiple system atrophy patients. Neuroepidemiology 46(4):261\u2013267. https:\/\/doi.org\/10.1159\/000444325","journal-title":"Neuroepidemiology"},{"issue":"11","key":"7410_CR6","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/mds.27894","volume":"34","author":"WG Meissner","year":"2019","unstructured":"Meissner WG, Fernagut P-O, Dehay B et al (2019) Multiple system atrophy: recent developments and future perspectives. Mov Disord 34(11):1629\u20131642. https:\/\/doi.org\/10.1002\/mds.27894","journal-title":"Mov Disord"},{"key":"7410_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn065","author":"SS O\u2019sullivan","year":"2021","unstructured":"O\u2019sullivan SS et al (2021) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain. https:\/\/doi.org\/10.1093\/brain\/awn065","journal-title":"Brain"},{"key":"7410_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104813","volume":"139","author":"A Foubert-Samier","year":"2020","unstructured":"Foubert-Samier A, Pavy-Le Traon A, Guillet F et al (2020) Disease progression and prognostic factors in multiple system atrophy: a prospective cohort study. Neurobiol Dis 139:104813. https:\/\/doi.org\/10.1016\/j.nbd.2020.104813","journal-title":"Neurobiol Dis"},{"key":"7410_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000324625.00404.15","author":"S Gilman","year":"2008","unstructured":"Gilman S et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000324625.00404.15","journal-title":"Neurology"},{"issue":"14","key":"7410_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1212\/WNL.0000000000008208","volume":"93","author":"P Cortelli","year":"2019","unstructured":"Cortelli P, Calandra-Buonaura G, Benarroch EE et al (2019) Stridor in multiple system atrophy: consensus statement on diagnosis, prognosis, and treatment. Neurology 93(14):630\u2013639. https:\/\/doi.org\/10.1212\/WNL.0000000000008208","journal-title":"Neurology"},{"key":"7410_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.03.027","author":"G Calandra-Buonaura","year":"2021","unstructured":"Calandra-Buonaura G, Alfonsi E, Vignatelli L et al (2021) Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.027","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"7410_CR12","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/mds.20255","volume":"19","author":"GK Wenning","year":"2004","unstructured":"Wenning GK, Tison F, Seppi K et al (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 19(12):1391\u20131402. https:\/\/doi.org\/10.1002\/mds.20255","journal-title":"Mov Disord"},{"key":"7410_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1044\/1058-0360.0601.77","volume":"6","author":"A Johnson","year":"1997","unstructured":"Johnson A, Jacobson B, Grywalski C, Silbergleit A, Jacobson G, Benninger M (1997) (1997) The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol 6:66\u201370","journal-title":"Am J Speech Lang Pathol"},{"issue":"6","key":"7410_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000503448","volume":"72","author":"M Balaguer","year":"2020","unstructured":"Balaguer M, Farinas J, Fichaux-Bourin P, Puech M, Pinquier J, Woisard V (2020) Validation of the French versions of the speech handicap index and the phonation handicap index in patients treated for cancer of the oral cavity or oropharynx. Folia Phoniatr Logop 72(6):464\u2013477. https:\/\/doi.org\/10.1159\/000503448","journal-title":"Folia Phoniatr Logop"},{"issue":"1","key":"7410_CR15","first-page":"45","volume":"130","author":"P Fichaux-Bourin","year":"2009","unstructured":"Fichaux-Bourin P, Woisard V, Grand S, Puech M, Bodin S (2009) Validation d\u2019un questionnaire d\u2019auto-evaluation de la parole (Parole Handicap Index). Rev Laryngol Otol Rhinol (Bord) 130(1):45\u201351","journal-title":"Rev Laryngol Otol Rhinol (Bord)"},{"issue":"5","key":"7410_CR16","first-page":"315","volume":"127","author":"V Woisard","year":"2006","unstructured":"Woisard V, Andrieux MP, Puech M (2006) Validation of a self-assessment questionnaire for swallowing disorders (Deglutition Handicap Index). Rev Laryngol Otol Rhinol (Bord) 127(5):315\u2013325","journal-title":"Rev Laryngol Otol Rhinol (Bord)"},{"key":"7410_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-021-10250-2","author":"R Speyer","year":"2021","unstructured":"Speyer R, Cordier R, Bouix C, Gallois Y, Woisard V (2021) Using classical test theory to determine the psychometric properties of the Deglutition Handicap Index. Dysphagia. https:\/\/doi.org\/10.1007\/s00455-021-10250-2","journal-title":"Dysphagia"},{"key":"7410_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00191-5","author":"C Gao","year":"2020","unstructured":"Gao C, Liu J, Tan Y, Chen S et al (2020) Freezing of gait in Parkinson\u2019s disease: pathophysiology, risk factors and treatments. Transl Neurodegener. https:\/\/doi.org\/10.1186\/s40035-020-00191-5","journal-title":"Transl Neurodegener"},{"key":"7410_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70327-7","author":"GK Wenning","year":"2013","unstructured":"Wenning GK, Geser F, Krismer F et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(12)70327-7","journal-title":"Lancet Neurol"},{"key":"7410_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2020.01.351","author":"S Grimaldi","year":"2020","unstructured":"Grimaldi S, Renaud M, Robert D et al (2020) Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with Multiple system atrophy compared with Parkinson\u2019s disease. Rev Neurol (Paris). https:\/\/doi.org\/10.1016\/j.neurol.2020.01.351","journal-title":"Rev Neurol (Paris)"},{"key":"7410_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2019.06.008","author":"PW Tipton","year":"2020","unstructured":"Tipton PW, Ekbom DC, Rutt AL, van Gerpen JA (2020) Vocal fold \u201cParalysis\u201d: an early sign in multiple system atrophy. J Voice. https:\/\/doi.org\/10.1016\/j.jvoice.2019.06.008","journal-title":"J Voice"},{"key":"7410_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00241","author":"T Warnecke","year":"2019","unstructured":"Warnecke T, Vogel A, Ahring S et al (2019) The shaking palsy of the larynx-potential biomarker for multiple system atrophy: a pilot study and literature review. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00241","journal-title":"Front Neurol"},{"key":"7410_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28220","author":"F Gandor","year":"2020","unstructured":"Gandor F, Vogel A, Claus I et al (2020) Laryngeal movement disorders in multiple system atrophy: a diagnostic biomarker? Mov Disord. https:\/\/doi.org\/10.1002\/mds.28220","journal-title":"Mov Disord"},{"key":"7410_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-3787(07)90355-0","author":"E Krim","year":"2007","unstructured":"Krim E, Yekhlef F, Chrysostome V, Ghorayeb I, Tison F (2007) Atrophie multisyst\u00e9matis\u00e9e\u202f: survie et facteurs pronostiques dans la cohorte \u00ab\u202fMSA-Aquitaine\u202f\u00bb. Revue Neurologique. https:\/\/doi.org\/10.1016\/S0035-3787(07)90355-0","journal-title":"Revue Neurologique"},{"key":"7410_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-021-00782-w","author":"J-A Palma","year":"2021","unstructured":"Palma J-A, Vernetti PM, Perez MA et al (2021) Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement. Clin Auton Res. https:\/\/doi.org\/10.1007\/s10286-021-00782-w","journal-title":"Clin Auton Res"},{"key":"7410_CR26","doi-asserted-by":"publisher","DOI":"10.1159\/000487800","author":"HH Lee","year":"2018","unstructured":"Lee HH, Seo HG, Kim K-D et al (2018) Characteristics of early oropharyngeal dysphagia in patients with multiple system atrophy. Neurodegener Dis. https:\/\/doi.org\/10.1159\/000487800","journal-title":"Neurodegener Dis"},{"key":"7410_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-015-9641-2","author":"H Taniguchi","year":"2015","unstructured":"Taniguchi H (2015) Esophageal involvement in multiple system atrophy. Dysphagia. https:\/\/doi.org\/10.1007\/s00455-015-9641-2","journal-title":"Dysphagia"},{"key":"7410_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-019-09990-z","author":"HJ Do","year":"2020","unstructured":"Do HJ, Seo HG, Lee HH et al (2020) Progression of oropharyngeal dysphagia in patients with multiple system atrophy. Dysphagia. https:\/\/doi.org\/10.1007\/s00455-019-09990-z","journal-title":"Dysphagia"},{"key":"7410_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.2.259","author":"J M\u00fcller","year":"2001","unstructured":"M\u00fcller J, Wenning GK, Verny M et al (2001) Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. https:\/\/doi.org\/10.1001\/archneur.58.2.259","journal-title":"Arch Neurol"},{"key":"7410_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-03948-7","author":"M Lieto","year":"2019","unstructured":"Lieto M (2019) Longitudinal study of a cohort of MSA-C patients in South Italy: survival and clinical features. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-019-03948-7","journal-title":"Neurol Sci"},{"key":"7410_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-199301000-00005","author":"EE Benarroch","year":"1993","unstructured":"Benarroch EE, Chang FL (1993) Central autonomic disorders. J Clin Neurophysiol. https:\/\/doi.org\/10.1097\/00004691-199301000-00005","journal-title":"J Clin Neurophysiol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07410-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-022-07410-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07410-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T04:07:56Z","timestamp":1660018076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-022-07410-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["7410"],"URL":"https:\/\/doi.org\/10.1007\/s00405-022-07410-x","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was waived by the local Ethics Committee of our university health centre in view of the retrospective nature of the study and since all the procedures performed were part of the routine care. It was also waived by the national commission for information technology and civil liberties.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Research involving human participants. The authors affirm that human research participants provided informed consent for publication. The authors did not receive support from any organization for the submitted work. The authors have no financial or proprietary interests in any material discussed in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Patients were invited to participate and informed consent was obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}